Global and United States Haemophilus Influenzae Type B Vaccine Market Report & Forecast 2024-2031

Report ID: 1873183 | Published Date: Jan 2025 | No. of Page: 94 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Haemophilus Influenzae Type B Vaccine Product Introduction
    1.2 Global Haemophilus Influenzae Type B Vaccine Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Haemophilus Influenzae Type B Vaccine Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Haemophilus Influenzae Type B Vaccine Sales in Volume for the Year 2017-2028
    1.3 United States Haemophilus Influenzae Type B Vaccine Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Haemophilus Influenzae Type B Vaccine Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Haemophilus Influenzae Type B Vaccine Sales in Volume for the Year 2017-2028
    1.4 Haemophilus Influenzae Type B Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Haemophilus Influenzae Type B Vaccine in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Haemophilus Influenzae Type B Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Haemophilus Influenzae Type B Vaccine Market Dynamics
        1.5.1 Haemophilus Influenzae Type B Vaccine Industry Trends
        1.5.2 Haemophilus Influenzae Type B Vaccine Market Drivers
        1.5.3 Haemophilus Influenzae Type B Vaccine Market Challenges
        1.5.4 Haemophilus Influenzae Type B Vaccine Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Haemophilus Influenzae Type B Vaccine Market Segment by Type
        2.1.1 Liquid Monovalent HIB
        2.1.2 Liquid Combination HIB
        2.1.3 Lyophilized Monovalent HIB
        2.1.4 Lyophilized Combination HIB
    2.2 Global Haemophilus Influenzae Type B Vaccine Market Size by Type
        2.2.1 Global Haemophilus Influenzae Type B Vaccine Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Haemophilus Influenzae Type B Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Haemophilus Influenzae Type B Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Haemophilus Influenzae Type B Vaccine Market Size by Type
        2.3.1 United States Haemophilus Influenzae Type B Vaccine Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Haemophilus Influenzae Type B Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Haemophilus Influenzae Type B Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Haemophilus Influenzae Type B Vaccine Market Segment by Application
        3.1.1 Hospital
        3.1.2 Research Institutions
        3.1.3 Pharmaceutical and Biotechnology Companies
        3.1.4 Academic Institutions
        3.1.5 Other
    3.2 Global Haemophilus Influenzae Type B Vaccine Market Size by Application
        3.2.1 Global Haemophilus Influenzae Type B Vaccine Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Haemophilus Influenzae Type B Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Haemophilus Influenzae Type B Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Haemophilus Influenzae Type B Vaccine Market Size by Application
        3.3.1 United States Haemophilus Influenzae Type B Vaccine Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Haemophilus Influenzae Type B Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Haemophilus Influenzae Type B Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Haemophilus Influenzae Type B Vaccine Competitor Landscape by Company
    4.1 Global Haemophilus Influenzae Type B Vaccine Market Size by Company
        4.1.1 Top Global Haemophilus Influenzae Type B Vaccine Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Manufacturer (2017-2022)
        4.1.3 Global Haemophilus Influenzae Type B Vaccine Sales by Manufacturer (2017-2022)
        4.1.4 Global Haemophilus Influenzae Type B Vaccine Price by Manufacturer (2017-2022)
    4.2 Global Haemophilus Influenzae Type B Vaccine Concentration Ratio (CR)
        4.2.1 Haemophilus Influenzae Type B Vaccine Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Haemophilus Influenzae Type B Vaccine in 2021
        4.2.3 Global Haemophilus Influenzae Type B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Haemophilus Influenzae Type B Vaccine Manufacturing Base Distribution, Product Type
        4.3.1 Global Haemophilus Influenzae Type B Vaccine Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Haemophilus Influenzae Type B Vaccine Product Type
        4.3.3 Date of International Manufacturers Enter into Haemophilus Influenzae Type B Vaccine Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Haemophilus Influenzae Type B Vaccine Market Size by Company
        4.5.1 Top Haemophilus Influenzae Type B Vaccine Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Haemophilus Influenzae Type B Vaccine Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Haemophilus Influenzae Type B Vaccine Sales by Players (2020, 2021 & 2022)
5 Global Haemophilus Influenzae Type B Vaccine Market Size by Region
    5.1 Global Haemophilus Influenzae Type B Vaccine Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Haemophilus Influenzae Type B Vaccine Market Size in Volume by Region (2017-2028)
        5.2.1 Global Haemophilus Influenzae Type B Vaccine Sales in Volume by Region: 2017-2022
        5.2.2 Global Haemophilus Influenzae Type B Vaccine Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Haemophilus Influenzae Type B Vaccine Market Size in Value by Region (2017-2028)
        5.3.1 Global Haemophilus Influenzae Type B Vaccine Sales in Value by Region: 2017-2022
        5.3.2 Global Haemophilus Influenzae Type B Vaccine Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Haemophilus Influenzae Type B Vaccine Market Size YoY Growth 2017-2028
        6.1.2 North America Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Haemophilus Influenzae Type B Vaccine Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Haemophilus Influenzae Type B Vaccine Market Size YoY Growth 2017-2028
        6.3.2 Europe Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Haemophilus Influenzae Type B Vaccine Market Size YoY Growth 2017-2028
        6.4.2 Latin America Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Novartis
        7.1.1 Novartis Corporation Information
        7.1.2 Novartis Description and Business Overview
        7.1.3 Novartis Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Novartis Haemophilus Influenzae Type B Vaccine Products Offered
        7.1.5 Novartis Recent Development
    7.2 Merck
        7.2.1 Merck Corporation Information
        7.2.2 Merck Description and Business Overview
        7.2.3 Merck Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Merck Haemophilus Influenzae Type B Vaccine Products Offered
        7.2.5 Merck Recent Development
    7.3 Sanofi
        7.3.1 Sanofi Corporation Information
        7.3.2 Sanofi Description and Business Overview
        7.3.3 Sanofi Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Sanofi Haemophilus Influenzae Type B Vaccine Products Offered
        7.3.5 Sanofi Recent Development
    7.4 GlaxoSmithKline
        7.4.1 GlaxoSmithKline Corporation Information
        7.4.2 GlaxoSmithKline Description and Business Overview
        7.4.3 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Products Offered
        7.4.5 GlaxoSmithKline Recent Development
    7.5 Takeda Pharmaceuticals Company
        7.5.1 Takeda Pharmaceuticals Company Corporation Information
        7.5.2 Takeda Pharmaceuticals Company Description and Business Overview
        7.5.3 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Products Offered
        7.5.5 Takeda Pharmaceuticals Company Recent Development
    7.6 Walvax Biotechnology
        7.6.1 Walvax Biotechnology Corporation Information
        7.6.2 Walvax Biotechnology Description and Business Overview
        7.6.3 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Products Offered
        7.6.5 Walvax Biotechnology Recent Development
    7.7 Lanzhou Institute of Biologica
        7.7.1 Lanzhou Institute of Biologica Corporation Information
        7.7.2 Lanzhou Institute of Biologica Description and Business Overview
        7.7.3 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Products Offered
        7.7.5 Lanzhou Institute of Biologica Recent Development
    7.8 Immunize BC
        7.8.1 Immunize BC Corporation Information
        7.8.2 Immunize BC Description and Business Overview
        7.8.3 Immunize BC Haemophilus Influenzae Type B Vaccine Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 Immunize BC Haemophilus Influenzae Type B Vaccine Products Offered
        7.8.5 Immunize BC Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Haemophilus Influenzae Type B Vaccine Industry Chain Analysis
    8.2 Haemophilus Influenzae Type B Vaccine Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Haemophilus Influenzae Type B Vaccine Distributors
    8.3 Haemophilus Influenzae Type B Vaccine Production Mode & Process
    8.4 Haemophilus Influenzae Type B Vaccine Sales and Marketing
        8.4.1 Haemophilus Influenzae Type B Vaccine Sales Channels
        8.4.2 Haemophilus Influenzae Type B Vaccine Distributors
    8.5 Haemophilus Influenzae Type B Vaccine Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Haemophilus Influenzae Type B Vaccine CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Haemophilus Influenzae Type B Vaccine Market Trends
    Table 3. Haemophilus Influenzae Type B Vaccine Market Drivers
    Table 4. Haemophilus Influenzae Type B Vaccine Market Challenges
    Table 5. Haemophilus Influenzae Type B Vaccine Market Restraints
    Table 6. Global Haemophilus Influenzae Type B Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Haemophilus Influenzae Type B Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Haemophilus Influenzae Type B Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Haemophilus Influenzae Type B Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Haemophilus Influenzae Type B Vaccine Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Haemophilus Influenzae Type B Vaccine Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Haemophilus Influenzae Type B Vaccine Sales by Manufacturer, (M Doses), 2017-2022
    Table 14. Global Haemophilus Influenzae Type B Vaccine Sales Share by Manufacturer, 2017-2022
    Table 15. Global Haemophilus Influenzae Type B Vaccine Price by Manufacturer (2017-2022) & (USD/Dose)
    Table 16. Global Haemophilus Influenzae Type B Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Haemophilus Influenzae Type B Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Haemophilus Influenzae Type B Vaccine as of 2021)
    Table 18. Top Players of Haemophilus Influenzae Type B Vaccine in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Haemophilus Influenzae Type B Vaccine Product Type
    Table 20. Date of International Manufacturers Enter into Haemophilus Influenzae Type B Vaccine Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Haemophilus Influenzae Type B Vaccine Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Haemophilus Influenzae Type B Vaccine Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Haemophilus Influenzae Type B Vaccine Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Haemophilus Influenzae Type B Vaccine Sales by Players, (M Doses), 2020, 2021 & 2022
    Table 26. United States Haemophilus Influenzae Type B Vaccine Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Haemophilus Influenzae Type B Vaccine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Haemophilus Influenzae Type B Vaccine Sales in Volume by Region (2017-2022) & (M Doses)
    Table 29. Global Haemophilus Influenzae Type B Vaccine Sales in Volume Forecast by Region (2023-2028) & (M Doses)
    Table 30. Global Haemophilus Influenzae Type B Vaccine Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Haemophilus Influenzae Type B Vaccine Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Haemophilus Influenzae Type B Vaccine Sales in Volume by Country (2017-2028) & (M Doses)
    Table 33. North America Haemophilus Influenzae Type B Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales in Volume by Region (2017-2028) & (M Doses)
    Table 35. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Haemophilus Influenzae Type B Vaccine Sales in Volume by Country (2017-2028) & (M Doses)
    Table 37. Europe Haemophilus Influenzae Type B Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Haemophilus Influenzae Type B Vaccine Sales in Volume by Country (2017-2028) & (M Doses)
    Table 39. Latin Americaa Haemophilus Influenzae Type B Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales in Volume by Country (2017-2028) & (M Doses)
    Table 41. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Novartis Corporation Information
    Table 43. Novartis Description and Business Overview
    Table 44. Novartis Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 45. Novartis Haemophilus Influenzae Type B Vaccine Product
    Table 46. Novartis Recent Development
    Table 47. Merck Corporation Information
    Table 48. Merck Description and Business Overview
    Table 49. Merck Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 50. Merck Product
    Table 51. Merck Recent Development
    Table 52. Sanofi Corporation Information
    Table 53. Sanofi Description and Business Overview
    Table 54. Sanofi Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 55. Sanofi Product
    Table 56. Sanofi Recent Development
    Table 57. GlaxoSmithKline Corporation Information
    Table 58. GlaxoSmithKline Description and Business Overview
    Table 59. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 60. GlaxoSmithKline Product
    Table 61. GlaxoSmithKline Recent Development
    Table 62. Takeda Pharmaceuticals Company Corporation Information
    Table 63. Takeda Pharmaceuticals Company Description and Business Overview
    Table 64. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 65. Takeda Pharmaceuticals Company Product
    Table 66. Takeda Pharmaceuticals Company Recent Development
    Table 67. Walvax Biotechnology Corporation Information
    Table 68. Walvax Biotechnology Description and Business Overview
    Table 69. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 70. Walvax Biotechnology Product
    Table 71. Walvax Biotechnology Recent Development
    Table 72. Lanzhou Institute of Biologica Corporation Information
    Table 73. Lanzhou Institute of Biologica Description and Business Overview
    Table 74. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 75. Lanzhou Institute of Biologica Product
    Table 76. Lanzhou Institute of Biologica Recent Development
    Table 77. Immunize BC Corporation Information
    Table 78. Immunize BC Description and Business Overview
    Table 79. Immunize BC Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 80. Immunize BC Product
    Table 81. Immunize BC Recent Development
    Table 82. Key Raw Materials Lists
    Table 83. Raw Materials Key Suppliers Lists
    Table 84. Haemophilus Influenzae Type B Vaccine Customers List
    Table 85. Haemophilus Influenzae Type B Vaccine Distributors List
    Table 86. Research Programs/Design for This Report
    Table 87. Key Data Information from Secondary Sources
    Table 88. Key Data Information from Primary Sources
List of Figures
    Figure 1. Haemophilus Influenzae Type B Vaccine Product Picture
    Figure 2. Global Haemophilus Influenzae Type B Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Haemophilus Influenzae Type B Vaccine Market Size 2017-2028 (US$ Million)
    Figure 4. Global Haemophilus Influenzae Type B Vaccine Sales 2017-2028 (M Doses)
    Figure 5. United States Haemophilus Influenzae Type B Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Haemophilus Influenzae Type B Vaccine Market Size 2017-2028 (US$ Million)
    Figure 7. United States Haemophilus Influenzae Type B Vaccine Sales 2017-2028 (M Doses)
    Figure 8. United States Haemophilus Influenzae Type B Vaccine Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Haemophilus Influenzae Type B Vaccine Market Share in Global, in Volume (M Doses) 2017-2028
    Figure 10. Haemophilus Influenzae Type B Vaccine Report Years Considered
    Figure 11. Product Picture of Liquid Monovalent HIB
    Figure 12. Product Picture of Liquid Combination HIB
    Figure 13. Product Picture of Lyophilized Monovalent HIB
    Figure 14. Product Picture of Lyophilized Combination HIB
    Figure 15. Global Haemophilus Influenzae Type B Vaccine Market Share by Type in 2022 & 2028
    Figure 16. Global Haemophilus Influenzae Type B Vaccine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 17. Global Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Type (2017-2028)
    Figure 18. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2028) & (M Doses)
    Figure 19. Global Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Type (2017-2028)
    Figure 20. Global Haemophilus Influenzae Type B Vaccine Price by Type (2017-2028) & (USD/Dose)
    Figure 21. United States Haemophilus Influenzae Type B Vaccine Market Share by Type in 2022 & 2028
    Figure 22. United States Haemophilus Influenzae Type B Vaccine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 23. United States Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Type (2017-2028)
    Figure 24. United States Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2028) & (M Doses)
    Figure 25. United States Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Type (2017-2028)
    Figure 26. United States Haemophilus Influenzae Type B Vaccine Price by Type (2017-2028) & (USD/Dose)
    Figure 27. Product Picture of Hospital
    Figure 28. Product Picture of Research Institutions
    Figure 29. Product Picture of Pharmaceutical and Biotechnology Companies
    Figure 30. Product Picture of Academic Institutions
    Figure 31. Product Picture of Other
    Figure 32. Global Haemophilus Influenzae Type B Vaccine Market Share by Application in 2022 & 2028
    Figure 33. Global Haemophilus Influenzae Type B Vaccine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 34. Global Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Application (2017-2028)
    Figure 35. Global Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2028) & (M Doses)
    Figure 36. Global Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Application (2017-2028)
    Figure 37. Global Haemophilus Influenzae Type B Vaccine Price by Application (2017-2028) & (USD/Dose)
    Figure 38. United States Haemophilus Influenzae Type B Vaccine Market Share by Application in 2022 & 2028
    Figure 39. United States Haemophilus Influenzae Type B Vaccine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 40. United States Haemophilus Influenzae Type B Vaccine Sales Market Share in Value by Application (2017-2028)
    Figure 41. United States Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2028) & (M Doses)
    Figure 42. United States Haemophilus Influenzae Type B Vaccine Sales Market Share in Volume by Application (2017-2028)
    Figure 43. United States Haemophilus Influenzae Type B Vaccine Price by Application (2017-2028) & (USD/Dose)
    Figure 44. North America Haemophilus Influenzae Type B Vaccine Sales in Volume Growth Rate 2017-2028 (M Doses)
    Figure 45. North America Haemophilus Influenzae Type B Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. U.S. Haemophilus Influenzae Type B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Canada Haemophilus Influenzae Type B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Europe Haemophilus Influenzae Type B Vaccine Sales in Volume Growth Rate 2017-2028 (M Doses)
    Figure 49. Europe Haemophilus Influenzae Type B Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 50. Germany Haemophilus Influenzae Type B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. France Haemophilus Influenzae Type B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. U.K. Haemophilus Influenzae Type B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Italy Haemophilus Influenzae Type B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Russia Haemophilus Influenzae Type B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales in Volume Growth Rate 2017-2028 (M Doses)
    Figure 56. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 57. China Haemophilus Influenzae Type B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Japan Haemophilus Influenzae Type B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. South Korea Haemophilus Influenzae Type B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. India Haemophilus Influenzae Type B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Australia Haemophilus Influenzae Type B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Taiwan Haemophilus Influenzae Type B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Indonesia Haemophilus Influenzae Type B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Thailand Haemophilus Influenzae Type B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Malaysia Haemophilus Influenzae Type B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Philippines Haemophilus Influenzae Type B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Latin America Haemophilus Influenzae Type B Vaccine Sales in Volume Growth Rate 2017-2028 (M Doses)
    Figure 68. Latin America Haemophilus Influenzae Type B Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 69. Mexico Haemophilus Influenzae Type B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Brazil Haemophilus Influenzae Type B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Argentina Haemophilus Influenzae Type B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales in Volume Growth Rate 2017-2028 (M Doses)
    Figure 73. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 74. Turkey Haemophilus Influenzae Type B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Saudi Arabia Haemophilus Influenzae Type B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. U.A.E Haemophilus Influenzae Type B Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 77. Haemophilus Influenzae Type B Vaccine Value Chain
    Figure 78. Haemophilus Influenzae Type B Vaccine Production Process
    Figure 79. Channels of Distribution
    Figure 80. Distributors Profiles
    Figure 81. Bottom-up and Top-down Approaches for This Report
    Figure 82. Data Triangulation
    Figure 83. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis
Merck
Sanofi
GlaxoSmithKline
Takeda Pharmaceuticals Company
Walvax Biotechnology
Lanzhou Institute of Biologica
Immunize BC
Frequently Asked Questions
Haemophilus Influenzae Type B Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Haemophilus Influenzae Type B Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Haemophilus Influenzae Type B Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Warm Paste

Warm Paste market is segmented by region (country), players, by Type and by Application. Players, ... Read More

Silicate Coatings

Silicate Coatings market is segmented by region (country), players, by Type and by Application. P ... Read More